A case of acute generalized exanthematous pustulosis following COVID‐19 infection and remdesivir

Key Clinical Message We report a challenging AGEP case following COVID‐19 infection and a history of remdesivir use. Our study highlights the importance of considering history of COVID‐19 and remdesivir as possible causative factors when visiting new‐onset AGEP patients.

Bibliographic Details
Published in:Clinical Case Reports
Main Authors: Yasamin Kalantari, Alireza Ghanadan, Ifa Etesami
Format: Article
Language:English
Published: Wiley 2023-06-01
Subjects:
acute generalized exanthematous pustulosis
adverse reaction
AGEP
COVID‐19
Online Access:https://doi.org/10.1002/ccr3.7423

Internet

https://doi.org/10.1002/ccr3.7423

Similar Items